Sweden
· Delayed Price · Currency is SEK Athanase Innovation AB Statistics
Total Valuation
Athanase Innovation AB has a market cap or net worth of SEK 437.49 million. The enterprise value is 9.39 million.
| Market Cap | 437.49M |
| Enterprise Value | 9.39M |
Important Dates
The next estimated earnings date is Friday, November 1, 2024.
| Earnings Date | Nov 1, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Athanase Innovation AB has 23.65 million shares outstanding. The number of shares has decreased by -14.16% in one year.
| Shares Outstanding | 23.65M |
| Shares Change (YoY) | -14.16% |
| Shares Change (QoQ) | -3.69% |
| Owned by Insiders (%) | 11.79% |
| Owned by Institutions (%) | 58.39% |
| Float | 6.42M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 4.37 |
| PB Ratio | 0.71 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.54 |
| EV / Sales | 0.08 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -0.20 |
Financial Position
The company has a current ratio of 5.74
| Current Ratio | 5.74 |
| Quick Ratio | 5.15 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -2.53% and return on invested capital (ROIC) is -2.78%.
| Return on Equity (ROE) | -2.53% |
| Return on Assets (ROA) | -2.53% |
| Return on Capital (ROIC) | -2.78% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.15 |
| Inventory Turnover | 1.40 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +2.78% in the last 52 weeks. The beta is 0.95, so Athanase Innovation AB's price volatility has been similar to the market average.
| Beta (5Y) | 0.95 |
| 52-Week Price Change | +2.78% |
| 50-Day Moving Average | 18.37 |
| 200-Day Moving Average | 17.07 |
| Relative Strength Index (RSI) | 53.39 |
| Average Volume (20 Days) | 3,858 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Athanase Innovation AB had revenue of SEK 112.71 million and -17.29 million in losses. Loss per share was -0.65.
| Revenue | 112.71M |
| Gross Profit | 61.61M |
| Operating Income | -30.56M |
| Pretax Income | -28.20M |
| Net Income | -17.29M |
| EBITDA | -16.93M |
| EBIT | -30.56M |
| Loss Per Share | -0.65 |
Balance Sheet
| Cash & Cash Equivalents | 428.12M |
| Total Debt | n/a |
| Net Cash | 428.12M |
| Net Cash Per Share | 18.10 |
| Equity (Book Value) | 613.76M |
| Book Value Per Share | 25.95 |
| Working Capital | 401.95M |
Cash Flow
In the last 12 months, operating cash flow was -46.30 million and capital expenditures -178,000, giving a free cash flow of -46.48 million.
| Operating Cash Flow | -46.30M |
| Capital Expenditures | -178,000 |
| Free Cash Flow | -46.48M |
| FCF Per Share | -1.97 |
Margins
Gross margin is 54.67%, with operating and profit margins of -27.12% and -15.34%.
| Gross Margin | 54.67% |
| Operating Margin | -27.12% |
| Pretax Margin | -25.02% |
| Profit Margin | -15.34% |
| EBITDA Margin | -15.02% |
| EBIT Margin | -27.12% |
| FCF Margin | -41.23% |
Dividends & Yields
Athanase Innovation AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 14.16% |
| Shareholder Yield | 14.16% |
| Earnings Yield | -3.51% |
| FCF Yield | -10.62% |
Stock Splits
The last stock split was on June 10, 2022. It was a reverse split with a ratio of 0.0625.
| Last Split Date | Jun 10, 2022 |
| Split Type | Reverse |
| Split Ratio | 0.0625 |